novartis hits acquisition trail
swiss drugmaker novartis euros purchases sandoz unit generic drug producer
novartis forecast germany hexal acquired hexal affiliate eon labs offered remaining shares novartis savings acquisitions novartis shares rose swiss francs trading
deal novartis sandoz overtake israel teva pharmaceuticals maker generics based newly merged producer estimated novartis merge departments adding job cuts
strong outlook sandoz jobs partially compensate reductions force generic drugs chemically identical expensive branded rivals producers sandoz copy branded patent protection expires sell cheaply
generic drugmakers worldwide predicted consolidation call fragmented initially convinced deal expensive acquisition birgit kuhlhoff sal oppenheim investment bank reuters strange acquisitions markets suffered pressure
